Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

273 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Evaluation of nutritional status in cancer patients receiving radiotherapy: a prospective study.
Unsal D, Mentes B, Akmansu M, Uner A, Oguz M, Pak Y. Unsal D, et al. Among authors: uner a. Am J Clin Oncol. 2006 Apr;29(2):183-8. doi: 10.1097/01.coc.0000198745.94757.ee. Am J Clin Oncol. 2006. PMID: 16601440
By a 6-month follow-up, the ratio of patients with malnutrition decreased to 8%. Nutritional status of all groups was found to improve during the 6-month follow-up period, except for the breast cancer group, which included no patients with severe malnutrition at any time. …
By a 6-month follow-up, the ratio of patients with malnutrition decreased to 8%. Nutritional status of all groups was found to improv …
Factors predicting recurrence in patients with grade III glial tumors: impact of adjuvant temozolomide on recurrence.
Gumusay O, Cetin B, Ozet A, Demirci U, Buyukberber S, Coskun U, Algin E, Uner A, Yildiz R, Kurt G, Benekli M. Gumusay O, et al. Among authors: uner a. J BUON. 2014 Oct-Dec;19(4):1035-40. J BUON. 2014. PMID: 25536613
METHODS: A retrospective analysis was carried out on 67 patients with grade III glial tumors between May 2007 and June 2013. ...
METHODS: A retrospective analysis was carried out on 67 patients with grade III glial tumors between May 2007 and June 2013. ...
Factors Influencing Chemotherapy Goal Perception in Newly Diagnosed Cancer Patients.
Gumusay O, Cetin B, Benekli M, Gurcan G, Ilhan MN, Bostankolu B, Ozet A, Uner A, Coskun U, Buyukberber S. Gumusay O, et al. Among authors: uner a. J Cancer Educ. 2016 Jun;31(2):308-13. doi: 10.1007/s13187-015-0827-y. J Cancer Educ. 2016. PMID: 25851203
We used a survey to evaluate the extent of perception of chemotherapy goal among cancer patients. Two hundred sixteen cancer patients who received chemotherapy for the first time participated in the study. ...In this study, there was a 51.9 % consistency between the …
We used a survey to evaluate the extent of perception of chemotherapy goal among cancer patients. Two hundred sixteen cancer patients …
Factors predicting the development of distant metastases in patients with head and neck squamous cell carcinoma: A retrospective study from a single centre.
Gumusay O, Ozet A, Buyukberber S, Baykara M, Coskun U, Cetin B, Uner A, Aydil U, Benekli M. Gumusay O, et al. Among authors: uner a. J BUON. 2015 Mar-Apr;20(2):521-6. J BUON. 2015. PMID: 26011345
PURPOSE: The presence of distant metastases (DMs) after the initial treatment of head and neck squamous cell carcinoma is associated with a poor outcome. ...
PURPOSE: The presence of distant metastases (DMs) after the initial treatment of head and neck squamous cell carcinoma is associated with …
Whole body 18F-FDG PET/CT imaging in the detection of primary tumours in patients with a metastatic carcinoma of unknown origin.
Kaya AO, Coskun U, Unlu M, Akdemir UO, Ozdemir NY, Zengin N, Benekli M, Yildiz R, Yaman E, Ozturk B, Gumus M, Uner A, Yamac D, Ucgul E, Buyukberber S. Kaya AO, et al. Among authors: uner a. Asian Pac J Cancer Prev. 2008 Oct-Dec;9(4):683-6. Asian Pac J Cancer Prev. 2008. PMID: 19256759
METHODS: The study population consisted of 43 patients with a biopsy proven metastatic disease, negative conventional diagnostic procedures (including CT/MRI/endoscopic procedures) and a whole body 18F-FDG PET/CT examination. ...CONCLUSION: Whole body 18F-FDG PET/CT …
METHODS: The study population consisted of 43 patients with a biopsy proven metastatic disease, negative conventional diagnostic proc …
Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy.
Unsal D, Akyurek N, Uner A, Erpolat OP, Han U, Akmansu M, Mentes BB, Dursun A. Unsal D, et al. Among authors: uner a. Am J Clin Oncol. 2008 Feb;31(1):55-63. doi: 10.1097/COC.0b013e318068b4e2. Am J Clin Oncol. 2008. PMID: 18376229
The data were also analyzed using a multivariate Cox proportional hazards model for prognosis as a secondary endpoint. RESULTS: Positive MMP-9 expression was observed in 70% of the tumors. ...
The data were also analyzed using a multivariate Cox proportional hazards model for prognosis as a secondary endpoint. RESULTS …
Clinical significance of serum MMP-2 and MMP-7 in patients with ovarian cancer.
Acar A, Onan A, Coskun U, Uner A, Bagriacik U, Atalay F, Unsal DK, Guner H. Acar A, et al. Among authors: uner a. Med Oncol. 2008;25(3):279-83. doi: 10.1007/s12032-007-9031-1. Epub 2007 Dec 11. Med Oncol. 2008. PMID: 18071928
As a conclusion, MMP-7 can be a useful serum marker to show disease activity in malignant ovarian tumors....
As a conclusion, MMP-7 can be a useful serum marker to show disease activity in malignant ovarian tumors....
Doppler sonographic evaluation of hemodynamic changes in colorectal liver metastases relative to liver size.
Oktar SO, Yücel C, Demirogullari T, Uner A, Benekli M, Erbas G, Ozdemir H. Oktar SO, et al. Among authors: uner a. J Ultrasound Med. 2006 May;25(5):575-82. doi: 10.7863/jum.2006.25.5.575. J Ultrasound Med. 2006. PMID: 16632780 Clinical Trial.
Hepatic perfusion changes in liver metastases were then compared with those in a control group. RESULTS: The liver volume of the patients with liver metastases was greater than that of the control group (P=.003). ...CONCLUSIONS: Our findings may support the hypothesis that …
Hepatic perfusion changes in liver metastases were then compared with those in a control group. RESULTS: The liver volume of the pati …
Discordances in HER2 status between primary gastric cancer and corresponding metastatic sites.
Gumusay O, Benekli M, Ekinci O, Baykara M, Ozet A, Coskun U, Demirci U, Uner A, Dursun A, Atak EY, Buyukberber S. Gumusay O, et al. Among authors: uner a. Jpn J Clin Oncol. 2015 May;45(5):416-21. doi: 10.1093/jjco/hyv020. Epub 2015 Mar 2. Jpn J Clin Oncol. 2015. PMID: 25732909
In the trastuzumab for GC trial, trastuzumab-based therapy demonstrated a significant overall survival benefit in patients with human epidermal growth factor receptor-2-positive advanced gastric cancer. ...Detection of a human epidermal growth factor receptor-2-posi …
In the trastuzumab for GC trial, trastuzumab-based therapy demonstrated a significant overall survival benefit in patients with human …
Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected liver metastases from colorectal cancer.
Turan N, Benekli M, Koca D, Ustaalioglu BO, Dane F, Ozdemir N, Ulas A, Oztop I, Gumus M, Ozturk MA, Berk V, Kucukoner M, Uner A, Balakan O, Helvaci K, Ozkan S, Yilmaz U, Buyukberber S; Anatolian Society of Medical Oncology. Turan N, et al. Among authors: uner a. Oncology. 2013;84(1):14-21. doi: 10.1159/000342429. Epub 2012 Oct 16. Oncology. 2013. PMID: 23076023
METHODS: A total of 229 consecutive patients who underwent resection for liver-confined colorectal liver metastases were retrospectively analyzed. ...With a median follow-up of 27 months after metastasectomy, the median recurrence-free survival (RFS) and overall sur …
METHODS: A total of 229 consecutive patients who underwent resection for liver-confined colorectal liver metastases were retrospectiv …
273 results
Jump to page
Feedback